Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective TherapySusanna Esposito, Nicola Principi, Gayatri Amirthalingam et al.|Frontiers in Immunology|2023Cited by 28
Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in EnglandHannah Higgins, Beverley J. Hunt, Mary Ramsay et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 10